SCHEMBL27485596

SCHEMBL27485596

Nc1cccc(C(=O)Nc2cccc(C(=O)c3ccccc3)c2)c1Cc1ccncc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNK3 O14649 1/20 0.49
▸ RAB9A P51151 2/20 0.46
▸ BLM P54132 1/20 0.46
▸ KDR P35968 5/20 0.45
▸ MAPT P10636 3/20 0.45
▸ ALDH1A1 P00352 3/20 0.45
▸ LMNA P02545 2/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ EGFR P00533 2/20 0.43
▸ NPY5R Q15761 1/20 0.43
▸ ABL1 P00519 1/20 0.43
▸ CSF1R P07333 1/20 0.43
▸ PDGFRB P09619 1/20 0.43
▸ KIT P10721 1/20 0.43
▸ FLT1 P17948 1/20 0.43
▸ FLT4 P35916 1/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27508410 0.89 KCNK3 (0.45) KCNK3KDRMAPTALDH1A1LMNA
SCHEMBL27486254 0.89 SMN1; SMN2 (0.53) KDRMAPTALDH1A1LMNASMN1; SMN2
SCHEMBL27468045 0.84 KDR (0.44) KCNK3KDRMAPTALDH1A1LMNA
SCHEMBL27484538 0.84 CYP17A1 (0.56) KCNK3RAB9AKDRMAPTALDH1A1
SCHEMBL27548625 0.84 KDR (0.59) KDRMAPTALDH1A1SMN1; SMN2FLT1
SCHEMBL27485938 0.84 PRKCI (0.53) RAB9AKDRMAPTLMNASMN1; SMN2
SCHEMBL27465575 0.84 P2RX1 (0.50) RAB9AKDRMAPTALDH1A1LMNA
SCHEMBL27485244 0.83 ALDH1A1 (0.52) RAB9AKDRMAPTALDH1A1LMNA
SCHEMBL27466657 0.81 PTGS1 (0.64) KDREGFRABL1CSF1RPDGFRB
SCHEMBL27519714 0.81 MEN1 (0.51) KDRMAPTALDH1A1LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN claimed
CN-1152014-C N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors ��˹��ŵ�� 2004-06-02 — — CN disclosed
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN disclosed
Send feedback